Back
Guggenheim Strategic Opportunities Fund Vs. Elevance Health, Inc. Industry Stock Comparison
Buy
59
GOF
Guggenheim Strategic Opportunities Fund
Last Price:
$12.24
Seasonality Move:
0.55%
Sell
40
ELV
Elevance Health, Inc.
Last Price:
$340.51
Seasonality Move:
10.44%
Buy
59
Guggenheim Strategic Opportunities Fund (GOF)
is a Buy
Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?
-
The current Guggenheim Strategic Opportunities Fund [GOF] share price is $12.25. The Score for GOF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
GOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Elevance Health, Inc. (ELV)
is a Sell
Is Elevance Health, Inc. a Buy, Sell or Hold?
-
The current Elevance Health, Inc. [ELV] share price is $340.69. The Score for ELV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ELV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GOF Stock Price Chart
What is Guggenheim Strategic Opportunities Fund's stock price today?
-
The Guggenheim Strategic Opportunities Fund share price today is $12.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ELV Stock Price Chart
What is Elevance Health, Inc.'s stock price today?
-
The Elevance Health, Inc. share price today is $340.69The current trend is moderately bearish and ELV is experiencing slight selling pressure.
GOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 43.93 | Sell |
| Chaikin Money Flow: | 1752434 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.99 - 12.39) | Buy |
| Bollinger Bands (100): | (12.73 - 15.13) | Sell |
ELV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.24 | Buy |
| Relative Strength Index (14 RSI): | 51.73 | Buy |
| Chaikin Money Flow: | -1312153 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (323.55 - 348.15) | Buy |
| Bollinger Bands (100): | (303.19 - 344.57) | Buy |
GOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.14 | Buy |
| 20-day SMA: | 12.18 | Buy |
| 50-day SMA: | 12.89 | Sell |
| 200-day SMA: | 14.39 | Sell |
| 8-day EMA: | 12.15 | Buy |
| 20-day EMA: | 12.26 | Sell |
| 50-day EMA: | 12.85 | Sell |
| 200-day EMA: | 14.13 | Sell |
ELV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 350.52 | Sell |
| 20-day SMA: | 339.23 | Buy |
| 50-day SMA: | 334.96 | Buy |
| 200-day SMA: | 356.36 | Sell |
| 8-day EMA: | 345.68 | Sell |
| 20-day EMA: | 340.57 | Buy |
| 50-day EMA: | 334.87 | Buy |
| 200-day EMA: | 354.59 | Sell |
Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Elevance Health, Inc. Earnings Growth & ELV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.97 per share, and a decrease next year of $3.04 per share.
Guggenheim Strategic Opportunities Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Elevance Health, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||